<VariationArchive VariationID="92515" VariationName="NM_000155.4(GALT):c.289_291del (p.Asn97del)" VariationType="Deletion" Accession="VCV000092515" Version="12" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-07-15" DateCreated="2015-06-28" MostRecentSubmission="2024-03-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="98424" VariationID="92515">
      <GeneList>
        <Gene Symbol="GALT" FullName="galactose-1-phosphate uridylyltransferase" GeneID="2592" HGNC_ID="HGNC:4135" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34646675" stop="34651035" display_start="34646675" display_stop="34651035" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="34646585" stop="34650594" display_start="34646585" display_stop="34650594" Strand="+" />
          </Location>
          <OMIM>606999</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000155.4(GALT):c.289_291del (p.Asn97del)</Name>
      <CanonicalSPDI>NC_000009.12:34647525:ACAAC:AC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="34647526" stop="34647528" display_start="34647526" display_stop="34647528" variantLength="3" positionVCF="34647525" referenceAlleleVCF="GACA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="34647523" stop="34647525" display_start="34647523" display_stop="34647525" variantLength="3" positionVCF="34647522" referenceAlleleVCF="GACA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>N97del</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000155.3" sequenceAccession="NM_000155" sequenceVersion="3" change="c.289_291delAAC">
            <Expression>NM_000155.3:c.289_291delAAC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.34647525_34647527del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.34647525_34647527del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.34647528_34647530del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.34647528_34647530del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009029.2" sequenceAccession="NG_009029" sequenceVersion="2" change="g.5940_5942del">
            <Expression>NG_009029.2:g.5940_5942del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_028966.1" sequenceAccession="NG_028966" sequenceVersion="1" change="g.344_346del">
            <Expression>NG_028966.1:g.344_346del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000155.4" sequenceAccession="NM_000155" sequenceVersion="4" change="c.289_291del" MANESelect="true">
            <Expression>NM_000155.4:c.289_291del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000146.2" sequenceAccession="NP_000146" sequenceVersion="2" change="p.Asn97del">
            <Expression>NP_000146.2:p.Asn97del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001258332.2" sequenceAccession="NM_001258332" sequenceVersion="2" change="c.50+270_50+272del">
            <Expression>NM_001258332.2:c.50+270_50+272del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA266758" DB="ClinGen" />
        <XRef Type="rs" ID="398123179" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000155.4(GALT):c.289_291del (p.Asn97del) AND not provided" Accession="RCV000078216" Version="8">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2013-01-09" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000155.4(GALT):c.289_291del (p.Asn97del) AND Galactosemia" Accession="RCV001831815" Version="2">
        <ClassifiedConditionList TraitSetID="10021">
          <ClassifiedCondition DB="MedGen" ID="C0016952">Galactosemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2018-03-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000155.4(GALT):c.289_291del (p.Asn97del) AND Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" Accession="RCV001389960" Version="7">
        <ClassifiedConditionList TraitSetID="949">
          <ClassifiedCondition DB="MedGen" ID="C0268151">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000155.4(GALT):c.289_291del (p.Asn97del) AND GALT-related disorder" Accession="RCV003974957" Version="1">
        <ClassifiedConditionList TraitSetID="90378">
          <ClassifiedCondition>GALT-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-13" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2015-06-28" MostRecentSubmission="2024-03-16">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15633893</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22944367</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25268296</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27176039</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7550229</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALT</URL>
        </Citation>
        <DescriptionHistory Dated="2022-08-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2022-08-07">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2021-05-10">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="90378" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="70345" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GALT-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GALT-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="949" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5173" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GALACTOSEMIA I</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0014" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0013" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606999.0011" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase</ElementValue>
                <XRef ID="Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206" DB="Genetic Alliance" />
                <XRef ID="124354006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactose-1-phosphate uridyltransferase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALT deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Galactosemia, classic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GALACTOSE-1-PHOSPHATE URIDYLYLTRANSFERASE DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="230400" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Transferase Deficiency Galactosemia</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term "galactosemia" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia (not covered in this chapter). This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest hypergonadatropic hypogonadism or premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications, including POI.</Attribute>
                <XRef ID="NBK1518" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="13639" />
                <XRef ID="13639" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301691</ID>
                <ID Source="BookShelf">NBK1518</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG ACT Sheets, 2010">
                <ID Source="PubMed">21938795</ID>
              </Citation>
              <Citation Type="general" Abbrev="CDC, 2012">
                <ID Source="PubMed">22475884</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">25473725</ID>
                <ID Source="BookShelf">NBK258640</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Hypergalactosemia-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics Algorithm, Primary or Secondary Hypergalactosemia (Galactose Elevated)</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Galactose-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated total galactose with normal GALT enzyme activity, Primary or Secondary Hypergalactosemia, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Classical-Galactosemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Absent/Reduced Galactose-1-Phosphate Uridyltransferase (GALT), Classic Galactosemia, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/GALT-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Galactosemia (GALT Deficiency), 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Galactosemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Galactosemia (GALT Deficiency, Classical Galactosemia), 2012</CitationText>
              </Citation>
              <XRef ID="352" DB="Orphanet" />
              <XRef ID="79239" DB="Orphanet" />
              <XRef ID="C0268151" DB="MedGen" />
              <XRef ID="MONDO:0009258" DB="MONDO" />
              <XRef Type="MIM" ID="230400" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10021" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="16954" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Galactose intolerance</ElementValue>
                <XRef ID="HP:0004919" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Galactosemia</ElementValue>
                <XRef ID="Galactosemia/2973" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018116" DB="MONDO" />
                <XRef ID="190745006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2424" />
                <XRef ID="2424" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000592259" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596356" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591986" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000569081" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">The term "galactosemia" refers to disorders of galactose metabolism that include classic galactosemia, clinical variant galactosemia, and biochemical variant galactosemia (not covered in this chapter). This GeneReview focuses on: Classic galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage, bleeding, and E coli sepsis in untreated infants. If a lactose-restricted diet is provided during the first ten days of life, the neonatal signs usually quickly resolve and the complications of liver failure, sepsis, and neonatal death are prevented; however, despite adequate treatment from an early age, children with classic galactosemia remain at increased risk for developmental delays, speech problems (termed childhood apraxia of speech and dysarthria), and abnormalities of motor function. Almost all females with classic galactosemia manifest hypergonadatropic hypogonadism or premature ovarian insufficiency (POI). Clinical variant galactosemia, which can result in life-threatening complications including feeding problems, failure to thrive, hepatocellular damage including cirrhosis, and bleeding in untreated infants. This is exemplified by the disease that occurs in African Americans and native Africans in South Africa. Persons with clinical variant galactosemia may be missed with newborn screening as the hypergalactosemia is not as marked as in classic galactosemia and breath testing is normal. If a lactose-restricted diet is provided during the first ten days of life, the severe acute neonatal complications are usually prevented. African Americans with clinical variant galactosemia and adequate early treatment do not appear to be at risk for long-term complications, including POI.</Attribute>
                <XRef ID="NBK1518" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301691</ID>
                <ID Source="BookShelf">NBK1518</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2021">
                <URL>https://www.acmg.net/PDFLibrary/Classical-Galactosemia-ACT-Sheet.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Absent/Reduced Galactose-1-Phosphate Uridyltransferase (GALT), Classic Galactosemia, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2021">
                <URL>https://www.acmg.net/PDFLibrary/GALT-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Galactosemia (GALT Deficiency), 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Galactosemia-Transition.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Transition to Adult Health Care ACT Sheet, Galactosemia (GALT Deficiency, Classical Galactosemia), 2012</CitationText>
              </Citation>
              <XRef ID="352" DB="Orphanet" />
              <XRef ID="C0016952" DB="MedGen" />
              <XRef ID="MONDO:0018116" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS230400" DB="OMIM" />
              <XRef Type="primary" ID="HP:0004919" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3117198" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4879686|MedGen:C0268151" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001591521" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22944367</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25268296</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27176039</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">7550229</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15633893</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22944367</ID>
          </Citation>
          <Comment>This variant, c.289_291del, results in the deletion of 1 amino acid(s) of the GALT protein (p.Asn97del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs770349232, gnomAD 0.0009%). This variant has been observed in individuals with galactosemia (PMID: 22944367, 25268296, 27176039; Invitae). ClinVar contains an entry for this variant (Variation ID: 92515). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. This variant disrupts the p.Asn97 amino acid residue in GALT. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 7550229, 15633893, 22944367). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.34647523_34647525del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268151" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8878032" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="37950254|GALT-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004787309" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The GALT c.289_291delAAC variant is predicted to result in an in-frame deletion (p.Asn97del). This variant has been reported in the homozygous state or heterozygous state with a second pathogenic GALT variant in individuals with galactosemia (Boutron et al. 2012. PubMed ID: 22944367; Schadewaldt et al. 2014. PubMed ID: 25268296; Garcia et al. 2016. PubMed ID: 27176039). It was also reported in a cohort of Swedish galactosemia patients, although no additional clinical or genetic information was reported about the patient in that cohort (Ohlsson et al. 2019. PubMed ID: 31194895). The p.Asn97 amino acid is involved in Hydrogen bonding with UDP-alpha-D-glucose, and disruption of this amino acid is predicted to impact both the enzyme active site and intersubunit interactions (Boutron et al. 2012. PubMed ID: 22944367; https://www.uniprot.org/uniprotkb/P07902). Several substitutions of the p.Asn97 amino acid (p.Asn97Asp, p.Asn97Ser, p.Asn97Ile) have been reported in patients with galactosemia (Boutron et al. 2012. PubMed ID: 22944367; Shin. 2004. PubMed ID: 15633893; ClinVar ID #811178). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. In summary, this variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000155.3:c.289_291delAAC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GALT-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="192146" SubmissionDate="2018-09-19" DateLastUpdated="2015-06-28" DateCreated="2014-01-17">
        <ClinVarSubmissionID localKey="2655_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000110054" DateUpdated="2015-06-28" DateCreated="2014-01-17" Type="SCV" Version="8" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2013-01-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="3" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="3" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GALT" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="-" referenceAllele="AAC" start="34647525" stop="34647527" variantLength="3" />
            <GeneLocation>NM_000155.3:Ex3</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD012848" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GALT</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4069296" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_000155.3:c.289_291del|Galactosemia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002085194" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-03-30">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000155.3:c.289_291del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Galactosemia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="192146" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4069296" TraitType="Disease" MappingType="Name" MappingValue="Galactosemia" MappingRef="Preferred">
        <MedGen CUI="C0016952" Name="Galactosemia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3117198" TraitType="Disease" MappingType="XRef" MappingValue="C0268151" MappingRef="MedGen">
        <MedGen CUI="C0268151" Name="Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8878032" TraitType="Disease" MappingType="Name" MappingValue="GALT-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="GALT-related disorder" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

